|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 缺血性脑卒中和出血性脑卒中患者发病前后血压的变化显示文摘《中国高血压防治指南2010》指出,急性脑卒中的血压处理缺乏足够的临床试验证据,参考建议如下:急性脑卒中溶栓前血压应控制在<185/110mm Hg(1mm Hg=0.133kPa)。对急性缺血性脑卒中发病24h内血压升高的患者应谨慎处理,收缩压≥180mm Hg或舒张压≥100mm Hg或伴有严重心功能不全、主动脉夹层、高血压脑病者,一般不予降压。降压的合理目标是24h内血压降低约15%。有高血压病史且正在服用降压药物者,如神经功能平稳,可于脑卒中发病后24h开始使用降压药物。因此,了解脑卒中患者发病前后的血压情况对临床治疗有重要的意义。Fischer等研究者探讨缺血性脑卒中和出血性脑卒中患者发病前后血压的变化情况。结果表明,缺血性脑卒中患者发病后首次测量的收缩压低于出血性脑卒中。与发病前比较,缺血性脑卒中发病后收缩压略升高(约10.6mm Hg),24h内轻度降低(约13.6mm Hg);而出血性脑卒中发病后,收缩压明显升高(约40.7mm Hg),24h内明显下降(约41.1mm Hg)。出血性脑卒中发病前几天及几周的平均收缩压逐渐增加,而缺血性脑卒中无明显变化。出血性脑卒中患者发病3h内的最高收缩压比发病前高50.0 mm Hg,而缺血性脑卒中则低5.2mm Hg。综上所述,与发病前比较,出血性脑卒中发病后收缩压升高,而缺血性脑卒中无明显变化。 | Fischer U Cooney MT Bull LM Silver LE Chalmers J Anderson CS Mehta Z Rothwell PM 林东杰 叶鹏 | 2014 | 中华高血压杂志2014，22，4： | 13 |
| 2 | 急性脊髓损伤患者治疗的临床操作指南:关于MRI基线在临床治疗决策与结果预测中作用的几点建议(英文)显示文摘The objective of this guideline is to outline the role of magnetic resonance imaging(MRI) in clinical decision making and outcome prediction in patients with traumatic spinal cord injury(SCI).Methods A systematic review of the literature was conducted to address key questions related to the use of MRI in patients with traumatic SCI.This review focused on longitudinal studies that controlled for baseline neurologic status.A multidisciplinary Guideline Development Group(GDG) used this information,their clinical expertise,and patient input to develop recommendations on the use of MRI for SCI patients.Based on GRADE(Grading of Recommendation,Assessment,Development and Evaluation),a strong recommendation is worded as ' we recommend,' whereas a weaker recommendation is indicated by 'we suggest.' Results Based on the limited available evidence and the clinical expertise of the GDG,our recommendations were:(1) 'We suggest that MRI be performed in adult patients with acute SCI prior to surgical intervention,when feasible,to facilitate improved clinical decision-making'(quality of evidence,very low) and(2) 'We suggest that MRI should be performed in adult patients in the acute period following SCI,before or after surgical intervention,to improve prediction of neurologic outcome '(quality of evidence,low).Conclusions These guidelines should be implemented into clinical practice to improve outcomes and prognostication for patients with SCI. | Fehlings MG Martin AR Tetreault LA Aarabi B Anderson P Arnold PM Brodke D Burns AS Chiba K Dettori JR Furlan JC Hawryluk G Holly LT Howley S Jeji T Kalsi-Ryan S Kotter M Kurpad S Kwon BK Marino RJ Massicotte E Merli G Middleton JW Nakashima H Nagoshi N Palmieri K Singh A Skelly AC Tsai EC Vaccaro A Wilson JR Yee A Harrop JS | 2017 | 中华神经外科疾病研究杂志2017，16，6： | 8 |
| 3 | Patient empowerment: Results of a randomized controlled trial显示文摘 | Anderson RM Funnell MM Butler PM | 1995 | Diabetes Care1995，18，7： | 1 |
| 4 | Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy 显示文摘 | Anderson PM Schroeder G Skubitz KM | 1998 | Cancer1998，83，7： | 1 |
| 5 | Efficacy safety and tolerability of quetiapine augmentation in treatment resistant depression:An open-lable pilot study 显示文摘 | Anderson IM Sarsfield A Haddad PM | 2009 | J Affect Disord2009，117，12： | 1 |
| 6 | Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease 显示文摘 | Calverley PM Anderson JA Celli B | 2007 | N Engl J Med2007，356，8： | 1 |
| 7 | Terminology显示文摘 | Anderson PA Andersson GB Arnold PM | 2012 | Spine2012，37，22： | 1 |
| 8 | Bias due to withdrawal in long - term randomised trials in COPD : evidence from the TORCH study 显示文摘 | Vestbo J Anderson JA Calverley PM | 2011 | Clin Respir J2011，5，1： | 1 |
| 9 | Prevalence and progression of osteoporosis in patients with COPD: results from the towards a revolution in COPD health study 显示文摘 | Ferguson GT Calverley PM Anderson JA | 2009 | Chest2009，136，6： | 1 |
| 10 | Salmeterol and flutica sone propionate and survival in chronic obstructive pulmonary dis- ease显示文摘 | Calverley PM Anderson JA Celli B | 2007 | N Engl J Med2007，356，77： | 1 |
| 11 | Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease显示文摘 | Calverley PM Anderson JA Celli B | 2007 | N Engl J Med2007，356，8： | 1 |
| 12 | Metastatic chondroblastoma with elevated creatine kinase and paraneoplastic neurologic autoimmunity显示文摘 | JOSHI DD ANDERSON PM MATSUMOTO J | 2003 | J Pediatr Hematol Oncol2003，25，11： | 1 |
| 13 | Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease显示文摘 | Calverley PM Anderson JA Celli B | 2007 | N Engl J Med2007，356，8： | 1 |
| 14 | yttrium mierospheres radioeml:olotherapy in desmoplastic small round cell tumor hepatic metastases显示文摘 | Subbiah V Murthy R Anderson PM | 2011 | J Clin Oncol2011，29，11： | 1 |
| 15 | Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease显示文摘 | Calvefley PM Anderson JA Celli B | | 0，，08： | 1 |
| 16 | Stroke re- habilitation services to accelerate hospital discharge and provide home-based care: an overview and cost analysis显示文摘 | Anderson C Ni Mhurchu C Brown PM | 2002 | Pharmacoeconomics2002，20，8： | 1 |
| 17 | Aerosol therapy for malignancy involving the lungs 显示文摘 | RAO RD MARKOVIC SN ANDERSON PM | 2003 | Curr Cancer Drug Targets2003，3，4： | 1 |
| 18 | Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease显示文摘 | Calverley PM Anderson JA Celli B | 2007 | N EnglJ Med2007，356，8： | 1 |
| 19 | Usefulness of impulse oscillometry for the assessment of airway hyperresponsiveness in mild-to-moderate adult asthma显示文摘 | Short PM Anderson WJ Manoharan A | 2015 | Ann Allergy Asthma Immunol2015，115，1： | 1 |
| 20 | Anti -CD3+IL-2 stimulated murine killer cell in vitro generation and in vivo antitumor activity显示文摘 | Anderson PM Blazar BR Bach FH | 1989 | J Immunol1989，142，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员